Objective: To compare the accuracy, costs and utility of using the National Death Index (NDI) and state-based cancer registries in determining the mortality status of a cohort of women diagnosed with ovarian cancer in the early 1990s. Methods: As part of a large prognostic study, identifying information on 822 women diagnosed with ovarian cancer between 1990 and 1993, was simultaneously submitted to the NDI and three state-based cancer registries to identify deceased women as of June 30, 1999. This was compared to the gold standard of ‘definite deaths’. A comparative evaluation was also made of the time and costs associated with the two methods. Results: Of the 450 definite deaths in our cohort the NDI correctly identified 417 and all of th...
© 2017 Background Death Certificate Only (DCO) cancer cases are commonly excluded from survival anal...
We have assessed the impact on survival estimates based on cancer registry data of incomplete ascert...
Objective: To measure progress, over the past decade, in reducing the disadvantage in cancer death r...
OBJECTIVE: To compare the accuracy, costs and utility of using the National Death Index (NDI) and st...
Abstract Objective: To assess the accuracy of the Australian National Death Index (NDI) in identifyi...
Objective: To assess the effectiveness of the National Death Index (NDI) in identifying participants...
BackgroundIn order to ensure accurate survival estimates, population-based cancer registries must as...
Registry based cancer incidence and mortality data are widely used for etiologic research, cancer co...
Background: This study quantifies the number of potentially “avoided”cancer deaths due to difference...
Introduction: Coded cause of death data from death certificates is important for estimating mortalit...
BackgroundThe National Death Index (NDI) is a centralized database containing information from death...
© AHHA 2015. Registries have key roles in cancer incidence, mortality and survival monitoring and in...
Background: Data from centralised, population-based statutory cancer registries are generally consid...
Background: Where people die can influence a number of indicators of the quality of dying. We aimed ...
Abstract. Registries have key roles in cancer incidence, mortality and survival monitoring and in sh...
© 2017 Background Death Certificate Only (DCO) cancer cases are commonly excluded from survival anal...
We have assessed the impact on survival estimates based on cancer registry data of incomplete ascert...
Objective: To measure progress, over the past decade, in reducing the disadvantage in cancer death r...
OBJECTIVE: To compare the accuracy, costs and utility of using the National Death Index (NDI) and st...
Abstract Objective: To assess the accuracy of the Australian National Death Index (NDI) in identifyi...
Objective: To assess the effectiveness of the National Death Index (NDI) in identifying participants...
BackgroundIn order to ensure accurate survival estimates, population-based cancer registries must as...
Registry based cancer incidence and mortality data are widely used for etiologic research, cancer co...
Background: This study quantifies the number of potentially “avoided”cancer deaths due to difference...
Introduction: Coded cause of death data from death certificates is important for estimating mortalit...
BackgroundThe National Death Index (NDI) is a centralized database containing information from death...
© AHHA 2015. Registries have key roles in cancer incidence, mortality and survival monitoring and in...
Background: Data from centralised, population-based statutory cancer registries are generally consid...
Background: Where people die can influence a number of indicators of the quality of dying. We aimed ...
Abstract. Registries have key roles in cancer incidence, mortality and survival monitoring and in sh...
© 2017 Background Death Certificate Only (DCO) cancer cases are commonly excluded from survival anal...
We have assessed the impact on survival estimates based on cancer registry data of incomplete ascert...
Objective: To measure progress, over the past decade, in reducing the disadvantage in cancer death r...